易方达、华夏等巨头，又有大动作

Core Viewpoint - The establishment of specialized fund subsidiaries marks a significant step for public funds in enhancing their professional capabilities and achieving differentiated development in the wealth management sector [2][6][12]. Group 1: Establishment of Fund Subsidiaries - Recently, several fund subsidiaries have been approved, with some already launching their first business operations [2][12]. - On July 3, E Fund announced the establishment of its wholly-owned subsidiary, E Fund Wealth Management Fund Sales (Guangzhou) Co., Ltd., with a registered capital of 100 million RMB [4][6]. - The subsidiary will focus on buy-side investment advisory services, aiming to transition from a "single product supplier" to a "comprehensive wealth management service provider" [7][12]. Group 2: Investment Activities - 华夏基金 has partnered with listed companies 乐普医疗 and 昭衍新药 to establish the 华夏致远创业投资基金, with a total subscription amount of 35 million RMB [9][10]. - The fund will primarily invest in unlisted companies within the biomedicine sector, focusing on molecular diagnostics and targeted therapies [9][10]. - The manager of 华夏股权, 陈斌, has extensive experience in the medical field and investment, which is expected to enhance the fund's capabilities in the medical investment sector [10]. Group 3: Industry Trends - The trend of establishing specialized subsidiaries is seen across the industry, with multiple fund companies applying for various types of subsidiaries, including those focused on REITs and operational services [12][13]. - The establishment of these subsidiaries is expected to improve the comprehensive wealth management capabilities of fund companies, better serving the wealth management needs of Chinese residents [13].